Table 3.
Multivariate logistic regression analysis among all patients according to PPIs use before and after PSM.
| Clinical endpoint | Before PSM | After PSM | |||||
| Adjusted OR | 95% CI | P | Adjusted OR | 95% CI | P | ||
| Odds ratio (OR) of each endpoint in PPIs group was calculated as compared with no PPIs group. GIB: gastrointestinal bleeding; MACCE: major adverse cardiovascular and cerebrovascular events; PPIs: proton pump inhibitors; PSM: propensity score matching. | |||||||
| Primary endpoint | |||||||
| MACCE | 0.857 | 0.742-0.990 | 0.0359 | 0.862 | 0.768-0.949 | 0.0245 | |
| Secondary endpoint | |||||||
| Cardiac death | 0.799 | 0.687-0.929 | 0.0035 | 0.813 | 0.709-0.936 | 0.0145 | |
| Re-infarction | 1.409 | 0.929-2.136 | 0.1067 | 1.378 | 0.979-2.156 | 0.2386 | |
| Stroke | 1.621 | 1.127-2.331 | 0.0091 | 1.635 | 1.341-2.517 | 0.0024 | |
| GIB | 5.847 | 3.376-9.302 | < 0.0001 | 5.471 | 3.127-8.796 | < 0.0001 | |